Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
TGF-beta/Smad Pathway
TGF-beta/Smad Pathway
/
Bcr-Abl
Bcr-Abl
Bcr-Abl
Products (5)
Asciminib
CAS No.:
1492952-76-7
Olverembatinib
CAS No.:
1257628-77-5
Vamotinib
CAS No.:
1416241-23-0
Asciminib Hydrochloride
CAS No.:
2119669-71-3
5-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,4-imidazolidinedione
CAS No.:
484049-04-9
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact